DXC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DXC Technology Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!


Werte in diesem Artikel
Aktien

8.00 EUR -0.22 EUR -2.62 %

NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DXC Technology Company ("DXC" or "the Company") (NYSE: DXC) and certain of its officers.

Class Definition

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DXC securities between May 26, 2021, and May 16, 2024, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/DXC.

Case Details

The complaint alleges throughout the Class Period, the Company misrepresented its ongoing "transformation journey" and the Company's ability to integrate previously acquired companies and business systems. The complaint continues to allege that while touting its ongoing success in implementing that integration, DXC repeatedly stressed its commitment to reducing the Company's restructuring and transaction, separation, and integration ("TSI") costs in order to increase its free cashflow and "unleash [its] true earnings power." In truth, Defendants knew or recklessly disregarded that the Company was only able to reduce its restructuring and TSI costs by limiting its integration efforts. As a result of Defendants' misrepresentations, shares of DXC common stock traded at artificially inflated prices throughout the Class Period. DXC also announced it would need to spend an additional $250 million to achieve the restructuring and integration process it falsely claimed to have been successfully implementing during the Class Period. These disclosures caused the price of DXC common stock to decline nearly 17%, from $19.88 per share to $16.52 per share.

What's Next?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/DXC or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in DXC you have until October 1, 2024, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com

Cision View original content:https://www.prnewswire.com/news-releases/dxc-investor-alert-bronstein-gewirtz--grossman-llc-announces-that-dxc-technology-company-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302215208.html

SOURCE Bronstein, Gewirtz & Grossman, LLC

Aktuelle DXC Technology Aktie News

Werbung

DXC Technology Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DXC Technology nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
09.08.19 DXC Technology Market Perform BMO Capital Markets
26.11.18 DXC Technology Outperform Cowen and Company, LLC
21.11.17 DXC Technology Overweight Barclays Capital
08.11.17 DXC Technology Hold Stifel, Nicolaus & Co., Inc.
08.11.17 DXC Technology Outperform RBC Capital Markets